New blood test could replace risky needle for prenatal genetic diagnosis
NCT ID NCT06147414
First seen Jan 22, 2026 · Last updated Jun 12, 2026 · Updated 23 times
Summary
This study is testing a new, safer blood test for pregnant women to diagnose genetic disorders like sickle cell disease and cystic fibrosis in their unborn babies. The test uses a small sample of the mother's blood, avoiding the miscarriage risk of traditional invasive procedures. Researchers aim to enroll 550 pregnant women to see how accurate and reliable this non-invasive method is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Cochin, Maternité Port-Royal, service de Gynécologie obstétrique
RECRUITINGParis, 75014, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.